Antibodies against phosphorylcholine in combination therapy with biologic agents

Details for Australian Patent Application No. 2011223222 (hide)

Owner Medirista Biotechnologies AB

Inventors Frostegard, Johan

Agent Shelston IP

Pub. Number AU-A-2011223222

PCT Pub. Number WO2011/107291

Priority 61/310,519 04.03.10 US; 61/349,410 28.05.10 US

Filing date 4 March 2011

Wipo publication date 9 September 2011

International Classifications

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

G01N 33/564 Investigating or analysing materials by specific methods not covered by groups - for pre-existing immune complex or autoimmune disease

G01N 33/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

27 September 2012 PCT application entered the National Phase

  PCT publication WO2011/107291 Priority application(s): WO2011/107291

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223226-Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms

2011223202-Security element having aligned magnetic pigments